Showing results (81-90 of 123) with videos related to

Sort By:
Pageof 13
Blood|February 25, 1999
TEL/PDGFbetaR induces hematologic malignancies in mice that respond to a specific tyrosine kinase inhibitorM H Tomasson, I R Williams, R Hasserjian, et al.
The New England Journal of Medicine|July 21, 1994
Langerhans'-cell histiocytosis (histiocytosis X)--a clonal proliferative diseaseC L Willman, L Busque, B B Griffith, et al.
Nucleic Acids Research|December 11, 1999
The Protein Data BankH M Berman, J Westbrook, Z Feng, et al.
Leukemia|August 1, 1997
TEL is one of the targets for deletion on 12p in many cases of childhood B-lineage acute lymphoblastic leukemiaS Takeuchi, T Seriu, C R Bartram, et al.
Leukemia|March 27, 2009
PML-RARalpha initiates leukemia by conferring properties of self-renewal to committed promyelocytic progenitorsS Wojiski, F C Guibal, T Kindler, et al.
Cancer|December 24, 1997
Intensified therapy for infants with acute lymphoblastic leukemia: results from the Dana-Farber Cancer Institute ConsortiumL B Silverman, T W McLean, R D Gelber, et al.
American Journal of Hematology|September 23, 1997
Prediction of therapy-related acute myelogenous leukemia (AML) and myelodysplastic syndrome (MDS) after autologous bone marrow transplant (ABMT) for lymphomaR D Legare, J G Gribben, M Maragh, et al.
Blood|November 24, 2001
The TEL/PDGFbetaR fusion in chronic myelomonocytic leukemia signals through STAT5-dependent and STAT5-independent pathwaysD W Sternberg, M H Tomasson, M Carroll, et al.
Blood|February 9, 2000
Effect of recombinant human erythropoietin combined with granulocyte/ macrophage colony-stimulating factor in the treatment of patients with myelodysplastic syndrome. GM/EPO MDS Study GroupJ A Thompson, D G Gilliland, J T Prchal, et al.
Biochemistry|March 19, 1996
Positive and negative cooperativities at subsequent steps of oxygenation regulate the allosteric behavior of multistate sebacylhemoglobinE Bucci, A Razynska, H Kwansa, et al.
Pageof 13